Extended local anesthesia enabled by flavonoid permeation enhancers
成果类型:
Article
署名作者:
Han, Yiyuan; Torre, Matthew; Ma, Xiaojing; Xue, Tianrui; Wang, Yuan; Jo, Sooyeon; Fujita, Akie; Bean, Bruce P.; Kohane, Daniel S.
署名单位:
Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Boston Children's Hospital; Baylor College of Medicine; Harvard University; Harvard Medical School
刊物名称:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN/ISSBN:
0027-8424; 1091-6490
DOI:
10.1073/pnas.2523195123
发表日期:
2026-03-10
页码:
e2523195123
关键词:
biological barrier
drug delivery
local anesthesia
chemical permeation enhancer
flavonoid
sodium-channels
PERIPHERAL-NERVE
tetrodotoxin
NEOSAXITOXIN
SAXITOXIN
na(v)1.8
COMBINATIONS
BUPIVACAINE
EPINEPHRINE
摘要:
Site 1 sodium channel blockers (S1SCBs), such as tetrodotoxin (TTX) and neosaxitoxin, are ultrapotent local anesthetics with low tissue toxicity. Their duration of action is relatively brief, but increasing the dose can lead to systemic toxicity. Here, we report that selected flavonoids-puerarin (PUE), naringenin, and kaempferol-prolong nerve block from S1SCBs 4-to 25-fold. Using both tympanic membrane (TM) permeation and sciatic nerve fluorescence distribution models, we demonstrate the flavonoids increase drug penetration across biological barriers (the TM and the barriers in and around nerve), suggesting that they act as chemical permeation enhancers (CPEs). Importantly, flavonoids exhibited minimal tissue toxicity compared to conventional CPEs. Coencapsulation of TTX and PUE into a liposomal delivery system further prolonged local anesthesia to over 25 d from a single injection. These findings establish flavonoid compounds as a safe class of CPEs and provide a platform of long-acting, nonopioid pain therapies. Flavonoids may be attractive alternatives to conventional CPEs in biomedical applications.
来源URL: